pancsm,oncology,MedTwitter,MedEd – MashupMD

Mashup Score: 0

Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer - 7 hour(s) ago

Brandon G. Smaglo, MD, FACP, discusses ongoing research with novel RAS inhibitors in pancreatic cancer.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer @drsmags @MDAndersonNews #pancsm #oncology #MedTwitter #MedEd https://t.co/fTBNmXX6zd

Mashup Score: 3

Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer - 2 day(s) ago

Brandon G. Smaglo, MD, FACP, discusses ongoing research with novel RAS inhibitors in pancreatic cancer.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer @drsmags @MDAndersonNews #pancsm #oncology #MedTwitter #MedEd https://t.co/fTBNmXX6zd

Mashup Score: 3

Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer - 13 day(s) ago

Brandon G. Smaglo, MD, FACP, discusses ongoing research with novel RAS inhibitors in pancreatic cancer.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Research Aims to Expand RAS Inhibitor Options in Pancreatic Cancer @drsmags @MDAndersonNews #pancsm #oncology #MedTwitter #MedEd https://t.co/fTBNmXX6zd